Piramal Pharma Limited · NSE: PPLPHARMA · BSE: 543635

Piramal Pharma

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 29 Jul 2026.

Q1 FY27 · Consolidated

Revenue
2,269.92₹ Cr
+17.4% vs year ago
Net profit
(69.39)₹ Cr
Loss narrowed vs year ago
EPS, basic
(0.52)₹
Loss narrowed vs year ago
Net margin
-3.1%
+1.2 pts vs year ago
Revenue₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹1,911.38 CrQ3 FY24: ₹1,958.57 CrQ4 FY24: ₹2,552.36 CrQ1 FY25: ₹1,951.14 CrQ2 FY25: ₹2,241.75 CrQ3 FY25: ₹2,204.22 CrQ4 FY25: ₹2,754.07 CrQ1 FY26: ₹1,933.71 CrQ2 FY26: ₹2,043.72 CrQ3 FY26: ₹2,139.87 CrQ4 FY26: ₹2,751.77 CrQ1 FY27: ₹2,269.92 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹5.02 CrQ3 FY24: ₹10.11 CrQ4 FY24: ₹101.27 CrQ1 FY25: ₹(88.64) CrQ2 FY25: ₹22.59 CrQ3 FY25: ₹3.68 CrQ4 FY25: ₹153.50 CrQ1 FY26: ₹(81.70) CrQ2 FY26: ₹(99.22) CrQ3 FY26: ₹(136.19) CrQ4 FY26: ₹(8.82) CrQ1 FY27: ₹(69.39) CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 20262,269.92+17.4%(69.39)Loss narrowed(0.52)29 Jul 2026
Q4 FY26Jan–Mar 20262,751.77−0.1%(8.82)Turned loss(0.07)28 Apr 2026
Q3 FY26Oct–Dec 20252,139.87−2.9%(136.19)Turned loss(1.03)29 Jan 2026
Q2 FY26Jul–Sep 20252,043.72−8.8%(99.22)Turned loss(0.75)05 Nov 2025
Q1 FY26Apr–Jun 20251,933.71−0.9%(81.70)Loss narrowed(0.62)28 Jul 2025
Q4 FY25Jan–Mar 20252,754.07+7.9%153.50+51.6%1.1614 May 2025
Q3 FY25Oct–Dec 20242,204.22+12.5%3.68−63.6%0.0328 Jan 2025
Q2 FY25Jul–Sep 20242,241.75+17.3%22.59+350.0%0.1724 Oct 2024
Q1 FY25Apr–Jun 20241,951.14+11.6%(88.64)Loss narrowed(0.67)29 Jul 2024
Q4 FY24Jan–Mar 20242,552.36+18.0%101.27+102.1%0.7711 May 2024
Q3 FY24Oct–Dec 20231,958.57+14.1%10.11Turned profit0.0831 Jan 2024
Q2 FY24Jul–Sep 20231,911.38+11.1%5.02Turned profit0.0417 Nov 2023
Q1 FY24Apr–Jun 20231,748.85—(98.58)—(0.83)03 Aug 2023
Q4 FY23Jan–Mar 20232,163.58—50.11—0.4225 May 2023
Q3 FY23Oct–Dec 20221,715.97—(90.18)—(0.76)10 Feb 2023
Q2 FY23Jul–Sep 20221,720.01—(37.34)—(0.31)22 Nov 2022
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 20261,124.95+16.0%113.48+0.3%0.8529 Jul 2026
Q4 FY26Jan–Mar 20261,489.06−11.9%261.63−5.6%1.9728 Apr 2026
Q3 FY26Oct–Dec 20251,195.81−4.2%128.91+8.5%0.9729 Jan 2026
Q2 FY26Jul–Sep 20251,127.26−12.2%196.33−6.5%1.4805 Nov 2025
Q1 FY26Apr–Jun 2025969.88−8.8%113.14+32.7%0.8528 Jul 2025
Q4 FY25Jan–Mar 20251,689.80+10.8%277.27+1.5%2.0914 May 2025
Q3 FY25Oct–Dec 20241,248.32+21.9%118.80+59.8%0.9028 Jan 2025
Q2 FY25Jul–Sep 20241,284.39+29.2%210.06+172.2%1.5924 Oct 2024
Q1 FY25Apr–Jun 20241,063.20+25.6%85.27Turned profit0.6429 Jul 2024
Q4 FY24Jan–Mar 20241,525.30+44.6%273.08+554.9%2.0611 May 2024
Q3 FY24Oct–Dec 20231,024.14+25.9%74.34Turned profit0.5631 Jan 2024
Q2 FY24Jul–Sep 2023994.24+20.0%77.16+63.0%0.6117 Nov 2023
Q1 FY24Apr–Jun 2023846.43—(33.36)—(0.28)03 Aug 2023
Q4 FY23Jan–Mar 20231,054.58—41.70—0.3525 May 2023
Q3 FY23Oct–Dec 2022813.29—(2.42)—(0.02)10 Feb 2023
Q2 FY23Jul–Sep 2022828.87—47.33—0.4022 Nov 2022

32 filings on record for this company.